Journal article
Cardiovascular events risk in office-masked nocturnal hypertension defined by home blood pressure monitoring
- Abstract:
-
Background
Nocturnal home blood pressure monitoring (HBPM) may identify people at higher cardiovascular disease (CVD) risk than expected.
Objectives
The aim of this study was to examine the association between office-masked nocturnal hypertension, defined by HBPM, and CVD risk in a clinical practice-based population.
Methods
Prospective observational study including Japanese high cardiovascular-risk participants. Three office blood pressures (OBPs) were taken on 2 different occasions. Nocturnal home blood pressure (HBP) was measured 3 times per night for 2 weeks. The association between office-masked nocturnal hypertension and time to first CVD events (fatal and nonfatal stroke or coronary heart disease) was examined using Cox regression.
Results
The cohort included 2,545 participants who were followed for a median of 7.8 years (18,116 person-years), during which 152 CVD events occurred. The proportions of participants with nocturnal normotension (OBP <140/90 mm Hg and nocturnal HBP <120/70 mm Hg), white-coat nocturnal hypertension (OBP ≥140/90 mm Hg and nocturnal HBP <120/70 mm Hg), office-masked nocturnal hypertension (OBP <140/90 mm Hg and nocturnal HBP ≥120/70 mm Hg), and sustained nocturnal hypertension (OBP ≥140/90 mm Hg and nocturnal HBP ≥120/70 mm Hg) were 25.3%, 14.4%, 23.2%, and 37.1%, respectively. Relative to nocturnal normotension, those with both office-masked nocturnal hypertension (adjusted HR: 1.72; 95% CI: 1.01-2.92) and sustained nocturnal hypertension (adjusted HR: 1.75; 95% CI: 1.03-2.96) had similarly increased CVD risk, even after adjustment for daytime HBP values.
Conclusions
Screening for office-masked nocturnal hypertension with HBPM identifies a potentially important group of patients with increased risk for incident CVD events for whom additional preventative measures may be appropriate.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.4MB, Terms of use)
-
- Publisher copy:
- 10.1016/j.jacadv.2024.101352
Authors
+ Wellcome Trust
More from this funder
- Funder identifier:
- https://ror.org/029chgv08
- Funding agency for:
- Sheppard, JP
- Grant:
- 211182/Z/18/Z
+ National Institute for Health and Care Excellence
More from this funder
- Funder identifier:
- https://ror.org/015ah0c92
- Funding agency for:
- McManus, RJ
+ SENSHIN Medical Research Foundation
More from this funder
- Funder identifier:
- https://ror.org/021tj4g88
- Funding agency for:
- Fujiwara, T
- Publisher:
- Elsevier
- Journal:
- JACC: Advances More from this journal
- Volume:
- 3
- Issue:
- 11
- Article number:
- 101352
- Place of publication:
- United States
- Publication date:
- 2024-11-07
- Acceptance date:
- 2024-09-16
- DOI:
- EISSN:
-
2772-963X
- ISSN:
-
2772-963X
- Pmid:
-
39600985
- Language:
-
English
- Keywords:
- Pubs id:
-
2062257
- Local pid:
-
pubs:2062257
- Deposit date:
-
2025-03-24
- ARK identifier:
Terms of use
- Copyright holder:
- Fujiwara et al.
- Copyright date:
- 2024
- Rights statement:
- © 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record